Drawing for PLASMACAP

USPTO serial 86039785

PLASMACAP

Reviewed by CopyMark Law Group

Reg. 6172150Status 700Renewal
Filing date
Status date
Registration date
Oct 13, 2020
Examiner
BIBB, SCOTT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PLASMACAP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,493*

Plus Government fees of $2,975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher J. Schulte

Christopher J. Schulte MERCHANT & GOULD P.C.P.O. BOX 2910MINNEAPOLIS, MN 55402-0910United States

Goods and services

ClassDescriptionStatusFirst use
001Resins, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate ion exchange, mixed mode, and affinity resinsACTIVE—
005Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteinsACTIVE—
009Protein chromatography equipment for capturing biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitateACTIVE—
037Construction of biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services in the field of construction of biopharmaceutical and plasma manufacturing servicesACTIVE—
040Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologicsACTIVE—
041Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipmentACTIVE—
042Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design of chromatography equipment, and design of biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineeringACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Oct 13, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 8, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 8, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 8, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 8, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 6, 2021CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Jul 1, 2021PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 13, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 28, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 28, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 8, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 18, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 17, 2020AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jun 17, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 2, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 2, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 2, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 1, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 3, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 3, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 3, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 27, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 24, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 24, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 22, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 27, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Sep 27, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Sep 27, 2019CNSISUSPENSION INQUIRY WRITTEN—
Sep 9, 2019RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Feb 5, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 5, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Feb 5, 2019CNSLSUSPENSION LETTER WRITTEN—
Dec 7, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 7, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 6, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 28, 2018GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jun 28, 2018GNSIINQUIRY TO SUSPENSION E-MAILED—
Jun 28, 2018CNSISUSPENSION INQUIRY WRITTEN—
May 30, 2018RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 27, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 27, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Nov 27, 2017CNSLSUSPENSION LETTER WRITTEN—
Oct 12, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 12, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 4, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 20, 2017GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 20, 2017GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 20, 2017CNSISUSPENSION INQUIRY WRITTEN—
Mar 17, 2017RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Sep 13, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 13, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Sep 13, 2016CNSLSUSPENSION LETTER WRITTEN—
Aug 16, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 16, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2016ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 9, 2016GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Feb 9, 2016GNSIINQUIRY TO SUSPENSION E-MAILED—
Feb 9, 2016CNSISUSPENSION INQUIRY WRITTEN—
Dec 16, 2015RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 30, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 30, 2015GNSLLETTER OF SUSPENSION E-MAILED—
May 30, 2015CNSLSUSPENSION LETTER WRITTEN—
Apr 28, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 28, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 23, 2015ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 25, 2014GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Oct 25, 2014GNSIINQUIRY TO SUSPENSION E-MAILED—
Oct 25, 2014CNSISUSPENSION INQUIRY WRITTEN—
Sep 24, 2014RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 24, 2014GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 24, 2014GNSLLETTER OF SUSPENSION E-MAILED—
Mar 24, 2014CNSLSUSPENSION LETTER WRITTEN—
Feb 19, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 19, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 12, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 11, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 11, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 11, 2014ALIEASSIGNED TO LIE—
Feb 9, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2013DOCKASSIGNED TO EXAMINER—
Aug 27, 2013MPMKNOTICE OF PSEUDO MARK E-MAILED—
Aug 24, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 20, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance